- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the DNA Damage Response in OSCC with TP53 Mutations
Authors
Keywords
-
Journal
JOURNAL OF DENTAL RESEARCH
Volume 97, Issue 6, Pages 635-644
Publisher
SAGE Publications
Online
2018-03-01
DOI
10.1177/0022034518759068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I pharmacological and pharmacodynamic study of MK-1775, a Wee1 tyrosine kinase inhibitor, in monotherapy and combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors.
- (2017) S. Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting mutant p53 for cancer therapy
- (2016) Moshe Oren et al. Aging-US
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
- (2016) Alice Soragni et al. CANCER CELL
- Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months
- (2016) Suzanne Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
- (2016) Kowthar Y. Salim et al. Oncotarget
- Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy
- (2016) Vladimir J. N. Bykov et al. Frontiers in Oncology
- Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation
- (2015) Sophia X. Pfister et al. CANCER CELL
- Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients
- (2015) A. A. Osman et al. CANCER RESEARCH
- Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer
- (2015) D. M. Neskey et al. CANCER RESEARCH
- Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins
- (2015) N. Tanaka et al. CLINICAL CANCER RESEARCH
- Exploiting replicative stress to treat cancer
- (2015) Matthias Dobbelstein et al. NATURE REVIEWS DRUG DISCOVERY
- The replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses
- (2014) Anitha Suram et al. AGING CELL
- Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas
- (2014) Tanguy Y. Seiwert et al. CLINICAL CANCER RESEARCH
- Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High-Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence
- (2014) A. A. Osman et al. MOLECULAR CANCER THERAPEUTICS
- Epidemiologic Trends in Head and Neck Cancer and Aids in Diagnosis
- (2014) Nadarajah Vigneswaran et al. Oral and Maxillofacial Surgery Clinics of North America
- NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)
- (2014) Luciana O. Almeida et al. FEBS Open Bio
- Cancer statistics for African Americans, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serine substitution of proline at codon 151 ofTP53confers gain of function activity leading to anoikis resistance and tumor progression of head and neck cancer cells
- (2013) Tong-Xin Xie et al. LARYNGOSCOPE
- Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53
- (2013) M. A. Gadhikar et al. MOLECULAR CANCER THERAPEUTICS
- Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers
- (2013) C. R. Pickering et al. Cancer Discovery
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition
- (2012) Amy D Guertin et al. Cancer Cell International
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
- (2012) W Yan et al. ONCOGENE
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
- (2011) N. V. Rajeshkumar et al. CLINICAL CANCER RESEARCH
- Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
- (2011) M. Lindenbergh-van der Plas et al. CLINICAL CANCER RESEARCH
- WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
- (2011) P. C. De Witt Hamer et al. CLINICAL CANCER RESEARCH
- MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
- (2011) K. A. Bridges et al. CLINICAL CANCER RESEARCH
- Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
- (2011) P T Ferrao et al. ONCOGENE
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
- (2011) N. Agrawal et al. SCIENCE
- More forks on the road to replication stress recovery
- (2011) C. Allen et al. Journal of Molecular Cell Biology
- MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil
- (2010) Hiroshi Hirai et al. CANCER BIOLOGY & THERAPY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Potential role of HDAC inhibitors in cancer therapy: Insights into oral squamous cell carcinoma
- (2010) A. Iglesias-Linares et al. ORAL ONCOLOGY
- Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
- (2009) M. Hashibe et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Mechanisms of Drug-Induced Mitotic Catastrophe in Cancer Cells
- (2009) Jose Portugal et al. CURRENT PHARMACEUTICAL DESIGN
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines
- (2009) Michael B Prystowsky et al. JOURNAL OF PATHOLOGY
- CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors
- (2009) Clark C Chen et al. Molecular Cancer
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- Head and neck cancer
- (2008) Athanassios Argiris et al. LANCET
- Recent Advances in Head and Neck Cancer
- (2008) Robert I. Haddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
- Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients
- (2008) Hao-Hueng Chang et al. ORAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started